Evaluation of Serum Β 2-Microglobulin as a Prognostic Indicator in Myelomatosis
British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1983.13
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 1983
Authors
Publisher
Springer Science and Business Media LLC